283 related articles for article (PubMed ID: 8803905)
1. Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis.
Petri M
Lupus; 1996 Jun; 5 Suppl 1():S16-22. PubMed ID: 8803905
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
[TBL] [Abstract][Full Text] [Related]
3. The lipid, lipoprotein, and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythematosus.
Hodis HN; Quismorio FP; Wickham E; Blankenhorn DH
J Rheumatol; 1993 Apr; 20(4):661-5. PubMed ID: 8496861
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.
Chen YM; Lin CH; Lan TH; Chen HH; Chang SN; Chen YH; Wang JS; Hung WT; Lan JL; Chen DY
Rheumatology (Oxford); 2015 Jul; 54(7):1244-9. PubMed ID: 25587177
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation of antimalarial drugs in systemic lupus erythematosus.
Wang C; Fortin PR; Li Y; Panaritis T; Gans M; Esdaile JM
J Rheumatol; 1999 Apr; 26(4):808-15. PubMed ID: 10229401
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine-induced pigmentation in two patients with systemic lupus erythematosus.
Reynaert S; Setterfield J; Black MM
J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):487-8. PubMed ID: 16643169
[No Abstract] [Full Text] [Related]
7. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
McLaurin EY; Holliday SL; Williams P; Brey RL
Neurology; 2005 Jan; 64(2):297-303. PubMed ID: 15668428
[TBL] [Abstract][Full Text] [Related]
8. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature.
Costedoat-Chalumeau N; Amoura Z; Huong DL; Lechat P; Piette JC
Autoimmun Rev; 2005 Feb; 4(2):111-5. PubMed ID: 15722258
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine blood assay as a marker of nonadherence in patients with systemic lupus erythematosus: comment on the article by Koneru et al.
Costedoat-Chalumeau N; Amoura Z; Marra D; Piette JC
Arthritis Rheum; 2008 Jan; 59(1):153; author reply 153-4. PubMed ID: 18163410
[No Abstract] [Full Text] [Related]
10. Hydroxychloroquine myopathy.
Richards AJ
J Rheumatol; 1998 Aug; 25(8):1642-3. PubMed ID: 9712114
[TBL] [Abstract][Full Text] [Related]
11. [Hydroxychloroquine: a new therapeutic approach to the thrombotic manifestations of antiphospholipid syndrome].
Szymezak J; Ankri A; Fischer AM; Darnige L
Rev Med Interne; 2010 Dec; 31(12):854-7. PubMed ID: 20888088
[TBL] [Abstract][Full Text] [Related]
12. [Psoriasis and systemic lupus erythematosus: a rare association with specific therapeutic problems].
Astudillo L; Sailler L; Carreiro M; Dahan S; Ollier S; Arlet P
Ann Med Interne (Paris); 2003 Feb; 154(1):3-6. PubMed ID: 12746653
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus.
Parke A; West B
J Rheumatol; 1996 Oct; 23(10):1715-8. PubMed ID: 8895146
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic sensorineural hearing loss in patients with systemic lupus erythematosus.
Roverano S; Cassano G; Paira S; Chiavarini J; Graf C; Rico L; Heredia C
J Clin Rheumatol; 2006 Oct; 12(5):217-20. PubMed ID: 17023806
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with blood hydroxychloroquine level in lupus patients: renal function could be important.
Lee JY; Luc S; Greenblatt DJ; Kalish R; McAlindon TE
Lupus; 2013 Apr; 22(5):541-2. PubMed ID: 23396569
[No Abstract] [Full Text] [Related]
16. Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting.
Koneru S; Shishov M; Ware A; Farhey Y; Mongey AB; Graham TB; Passo MH; Houk JL; Higgins GC; Brunner HI
Arthritis Rheum; 2007 Aug; 57(6):1000-6. PubMed ID: 17665465
[TBL] [Abstract][Full Text] [Related]
17. Steroid-induced diabetes mellitus in systemic lupus erythematosus patients: analysis from a Malaysian multi-ethnic lupus cohort.
Shaharir SS; Gafor AH; Said MS; Kong NC
Int J Rheum Dis; 2015 Jun; 18(5):541-7. PubMed ID: 25294584
[TBL] [Abstract][Full Text] [Related]
18. Lupus cystitis in association with severe gastrointestinal manifestations in an adolescent.
Dancey P; Constantin E; Duffy CM; Scuccimarri R
J Rheumatol; 2005 Jan; 32(1):178-80. PubMed ID: 15630745
[TBL] [Abstract][Full Text] [Related]
19. Relapsed hydroxychloroquine induced thrombocytopenia in a systemic lupus erythematosus patient.
Antón Vázquez V; Pascual L; Corominas H; Giménez Torrecilla I
Reumatol Clin; 2017; 13(5):294-296. PubMed ID: 27263963
[TBL] [Abstract][Full Text] [Related]
20. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group.
Costedoat-Chalumeau N; Amoura Z; Duhaut P; Huong DL; Sebbough D; Wechsler B; Vauthier D; Denjoy I; Lupoglazoff JM; Piette JC
Arthritis Rheum; 2003 Nov; 48(11):3207-11. PubMed ID: 14613284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
